Inhibrx Biosciences, Inc. INBX Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Inhibrx Biosciences, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s net margin?
- Inhibrx Biosciences, Inc. (INBX) reported net margin of -10,773.5% in Q4 2025.
- How has Inhibrx Biosciences, Inc.'s net margin changed year-over-year?
- Inhibrx Biosciences, Inc.'s net margin decreased by 101.2% year-over-year, from 867,718.5% to -10,773.5%.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s net margin?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s net margin has grown at a -10.4% compound annual growth rate (CAGR), from -13,408.9% to -10,773.5%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.